Allergy Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Allergy Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 24% to $55,199,000. Profit margin reached -73%. Total operating expenses were $64,994,000.
Profit Margin
| 2010 | 40.75M | 586K | 1.44% |
|---|---|---|---|
| 2011 | 41.55M | -2.66M | -6.41% |
| 2012 | 41.28M | 823K | 1.99% |
| 2015 | 43.23M | 108K | 0.25% |
| 2016 | 48.50M | -13.07M | -26.95% |
| 2018 | 68.34M | -7.53M | -11.02% |
| 2019 | 73.71M | 3.46M | 4.7% |
| 2021 | 84.33M | 2.88M | 3.42% |
| 2022 | 72.76M | -13.77M | -18.93% |
| 2024 | 55.19M | -40.21M | -72.86% |
AGY.L Income Statement (2010 – 2023)
| 2023 | 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 55.19M | 72.76M | 84.33M | 73.71M | 68.34M | 48.50M | 43.23M | 41.28M | 41.55M | 40.75M |
Cost of revenue | 25.46M | 23.81M | 22.53M | 18.37M | 17.01M | 14.07M | 12.17M | 13.67M | 13.22M | 11.16M |
Gross profit | 29.73M | 48.95M | 61.79M | 55.33M | 51.33M | 34.43M | 31.05M | 27.61M | 28.33M | 29.58M |
Operating exp. | ||||||||||
Research and development | 22.9M | 15.65M | 12.88M | 6.95M | 16.01M | 16.22M | 3.12M | 2.09M | 1.67M | 2.21M |
Selling and marketing | 19.59M | 26.00M | 25.2M | 26.99M | 27.13M | 20.22M | 17.06M | 17.88M | 17.52M | 16.14M |
Total operating expenses | 64.99M | 61.95M | 59.15M | 51.12M | 58.24M | 46.52M | 30.47M | 26.51M | 26.21M | 27.28M |
Operating income | -35.25M | -13.00M | 2.64M | -1.83M | -6.70M | -12.12M | 739K | 1.09M | 2.11M | 2.30M |
Other income (expenses), net | -3.90M | -396K | -941K | 6.12M | -166K | -113K | -71K | -452K | 4.43M | 2.42M |
Income before tax | -39.16M | -13.39M | 3.09M | 4.29M | -6.89M | -12.06M | 654K | 640K | -2.31M | -116K |
Income tax expense | 1.05M | 379K | 204K | 826K | 637K | 1.00M | 546K | -183K | 349K | -702K |
Net income | -40.21M | -13.77M | 2.88M | 3.46M | -7.53M | -13.07M | 108K | 823K | -2.66M | 586K |
Earnings per share | ||||||||||
Basic EPS | -0.01 | -0.00 | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 | 0.00 | -0.00 | 0.00 |
Diluted EPS | -0.01 | -0.00 | 0.00 | 0.00 | -0.01 | -0.02 | 0.00 | 0.00 | -0.00 | 0.00 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |